Patients with diffuse large B cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.

Visco C;Tzankov A;Xu Monette ZY;Miranda RN;Tai YC;Li Y;Liu WM;d'Amore ES;Li Y;Montes Moreno S;Dybkaer K;Chiu A;Orazi A;Zu Y;Bhagat G;Wang HY;Dunphy CH;O' Neill S;Hsi ED;Zhao XF;Choi WW;Zhao X;van Krieken JH;Huang Q;Ai W;PONZONI , MAURILIO;Ferreri AJ;Kahl BS;Winter JN;Go RS;Dirnhofer S;Piris MA;Møller MB;Wu L;Medeiros LJ;Young K.H.

2012-01-01